{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:05:07Z","timestamp":1788350707988,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejphar.2025.177381","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:39:35Z","timestamp":1739461175000},"page":"177381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Expanding the horizons of bicyclol in multiple diseases: Mechanisms, therapeutic implications and challenges"],"prefix":"10.1016","volume":"993","author":[{"given":"Heng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177381_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084162","article-title":"New insights into pathomechanisms and treatment possibilities for lung silicosis","volume":"22","author":"Adamcakova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177381_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1089-3261(05)70168-9","article-title":"Hepatic fibrosis. Pathogenesis and principles of therapy","volume":"5","author":"Albanis","year":"2001","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.177381_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5853\/jos.2019.02978","article-title":"Beyond the brain: the systemic pathophysiological response to acute ischemic stroke","volume":"22","author":"Balch","year":"2020","journal-title":"J Stroke"},{"key":"10.1016\/j.ejphar.2025.177381_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12192-008-0034-4","article-title":"Bicyclol: a novel antihepatitis drug with hepatic heat shock protein 27\/70-inducing activity and cytoprotective effects in mice","volume":"13","author":"Bao","year":"2008","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.ejphar.2025.177381_bib5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1124\/mol.108.053280","article-title":"Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-Induced liver injury through suppression of nuclear factor-kappaB in mice","volume":"75","author":"Bao","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/aps.2009.194","article-title":"Bicyclol protects HepG2 cells against D-galactosamine-induced apoptosis through inducing heat shock protein 27 and mitochondria associated pathway","volume":"31","author":"Bao","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.177381_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10286021003769924","article-title":"Involvement of HSP70 in the protection of bicyclol on apoptosis of HepG2 cells intoxicated by d-galactosamine","volume":"12","author":"Bao","year":"2010","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib8","article-title":"Novel therapies for the treatment of drug-induced liver injury: a systematic review","volume":"12","author":"Beni\u0107","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib9","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American heart association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177381_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.46.4.443","article-title":"Is liver fibrosis reversible?","volume":"46","author":"Benyon","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.177381_bib11","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib12","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177381_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1084\/jem.179.5.1437","article-title":"Interferon gamma receptor deficient mice are resistant to endotoxic shock","volume":"179","author":"Car","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/00498254.2023.2222385","article-title":"Investigation on the in vitro metabolism of bicyclol using liver microsomes, hepatocytes and human recombinant cytochrome P450 enzymes","volume":"53","author":"Chen","year":"2023","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2025.177381_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/mol.114.097584","article-title":"A sexual dimorphism influences bicyclol-induced hepatic heat shock factor 1 activation and hepatoprotection","volume":"88","author":"Chen","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10557-022-07356-6","article-title":"Bicyclol attenuates obesity-induced cardiomyopathy via inhibiting NF-\u03baB and MAPK signaling pathways","volume":"37","author":"Chen","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2025.177381_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/med-2018-0010","article-title":"Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China","volume":"13","author":"Chen","year":"2018","journal-title":"Open Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-019-1005-1","article-title":"Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience","volume":"19","author":"Chi","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177381_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5588\/ijtld.14.0579","article-title":"Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease","volume":"19","author":"Chu","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ejphar.2025.177381_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1631\/jzus.B1200263","article-title":"Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats","volume":"14","author":"Cui","year":"2013","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.ejphar.2025.177381_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejphar.2016.09.002","article-title":"Induction of heat shock protein 27 by bicyclol attenuates d-galactosamine\/lipopolysaccharide-induced liver injury","volume":"791","author":"Dai","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/14728222.2018.1464139","article-title":"MyD88 as a therapeutic target for inflammatory lung diseases","volume":"22","author":"Di Padova","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2025.177381_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5588\/ijtld.23.0038","article-title":"Efficacy and safety of bicyclol for treating patients with antituberculosis drug-induced liver injury","volume":"28","author":"Du","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ejphar.2025.177381_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104945","article-title":"Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: more friend than foe","volume":"159","author":"Fan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108797","article-title":"Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: target the target, not the arrow","author":"Fantini","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177381_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0039-6109(03)00226-3","article-title":"Early molecular and genetic determinants of primary liver malignancy","volume":"84","author":"Feitelson","year":"2004","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ejphar.2025.177381_bib28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.1840080513","article-title":"Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic","volume":"8","author":"Fr\u00e9neaux","year":"1988","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2025.177381_bib29","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis -- from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177381_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116958","article-title":"Bicyclol mitigates lipopolysaccharide-induced acute lung injury through myeloid differentiation factor 88 inhibition","volume":"487","author":"Fu","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib31","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin","volume":"76","author":"Galanos","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.177381_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/00325481.2022.2063568","article-title":"Effect of berberine and bicyclol on Chinese patients with nonalcoholic fatty liver disease: a retrospective study","volume":"134","author":"Geng","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejphar.2025.177381_bib33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1119299","article-title":"Medicine. A portfolio model of drug development for tuberculosis","volume":"311","author":"Glickman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177381_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2006.09.009","article-title":"Reperfusion injury: does it exist?","volume":"42","author":"Gross","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177381_bib35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/10286021003789047","article-title":"Effects of bicyclol on immunological liver fibrosis in rats","volume":"12","author":"Gu","year":"2010","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib36","volume":"vol. 177","author":"Hansen","year":"2015"},{"key":"10.1016\/j.ejphar.2025.177381_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34633-y","article-title":"Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model","volume":"8","author":"Henkel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177381_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105518","article-title":"Comparison and identification of metabolic profiling of bicyclol in rats, dogs and humans in vitro and in vivo","volume":"154","author":"Hu","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2025.177381_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.lfs.2006.02.025","article-title":"Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action","volume":"79","author":"Hu","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177381_bib40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.apsb.2019.01.013","article-title":"Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication","volume":"9","author":"Huang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.177381_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114947","article-title":"Identification of bicyclol metabolites in rat plasma, urine and feces by UPLC-Q-TOF-MS\/MS and evaluation of the efficacy and safety of these metabolites based on network pharmacology and molecular docking combined with toxicity prediction","volume":"220","author":"Huang","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2025.177381_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105170","article-title":"Scoparone as a therapeutic drug in liver diseases: pharmacology, pharmacokinetics and molecular mechanisms of action","volume":"160","author":"Hui","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0889-8553(21)00227-2","article-title":"Morphologic spectrum of drug-induced hepatic disease","volume":"24","author":"Ishak","year":"1995","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2025.177381_bib44","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/ajrccm.154.4.8887610","article-title":"Transforming growth factor-beta (TGF-beta) in silicosis","volume":"154","author":"Jagirdar","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/03639045.2022.2106238","article-title":"Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis in mice","volume":"48","author":"Jia","year":"2022","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejphar.2025.177381_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.physiol.67.040403.103635","article-title":"Molecular and evolutionary basis of the cellular stress response","volume":"67","author":"K\u00fcltz","year":"2005","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2025.177381_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177381_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177381_bib49","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1152\/japplphysiol.01267.2001","article-title":"Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance","volume":"92","author":"Kregel","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2025.177381_bib50","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/hep.23534","article-title":"Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome","volume":"51","author":"Kumar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.177381_bib51","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0006-2952(91)90640-Q","article-title":"Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice","volume":"41","author":"Labbe","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib52","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199510263331706","article-title":"Drug-induced hepatotoxicity","volume":"333","author":"Lee","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib53","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fphar.2018.01438","article-title":"Bicyclol attenuates liver inflammation induced by infection of hepatitis C virus via repressing ROS-mediated activation of MAPK\/NF-\u03baB signaling pathway","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib54","article-title":"Combined use of bicyclol and berberine alleviates mouse nonalcoholic fatty liver disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039700","article-title":"Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejphar.2025.177381_bib56","article-title":"Bicyclol regulates hepatic gluconeogenesis in rats with type 2 diabetes and non-alcoholic fatty liver disease by inhibiting inflammation","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib57","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3748\/wjg.v10.i12.1775","article-title":"Inhibition of Fas\/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol","volume":"10","author":"Li","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177381_bib58","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0300060514527058","article-title":"Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer","volume":"42","author":"Li","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib59","article-title":"Bicyclol alleviates atherosclerosis by manipulating gut microbiota","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.ejphar.2025.177381_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1485065","article-title":"Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities","volume":"15","author":"Liao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157340609787049316","article-title":"Bicyclol: a novel drug for treating chronic viral hepatitis B and C","volume":"5","author":"Liu","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177381_bib62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3748\/wjg.v11.i5.665","article-title":"Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study","volume":"11","author":"Liu","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177381_bib63","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1478-3231.2005.01103.x","article-title":"Mechanism of protective action of bicyclol against CCl-induced liver injury in mice","volume":"25","author":"Liu","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2025.177381_bib64","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12967-024-05399-x","article-title":"Bicyclol attenuates pulmonary fibrosis with silicosis via both canonical and non-canonical TGF-\u03b21 signaling pathways","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib65","article-title":"Protective effect of bicyclol on anti-tuberculosis drug induced liver injury in rats","volume":"22","author":"Liu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177381_bib66","first-page":"2023","volume":"vol. 11","author":"Liu","year":"2020"},{"key":"10.1016\/j.ejphar.2025.177381_bib67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.177381_bib68","first-page":"206","article-title":"Bicyclol attenuates pro-inflammatory cytokine and chemokine productions in CpG-DNA-stimulated L02 hepatocytes by inhibiting p65-NF-kappaB and p38-MAPK activation","volume":"65","author":"Lou","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejphar.2025.177381_bib69","first-page":"942","article-title":"Effects of bicyclol on aflatoxin B1 metabolism and hepatotoxicity in rats","volume":"23","author":"Lu","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.177381_bib70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/10286020.2024.2340072","article-title":"Characterization of the metabolic contributions of cytochrome P450 isoforms to bicyclol using the relative activity factor method","volume":"26","author":"Luo","year":"2024","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pupt.2010.12.005","article-title":"Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice","volume":"24","author":"Luo","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177381_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/tcr.202400182","article-title":"Target discovery driven by chemical biology and computational biology","author":"Lyu","year":"2025","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejphar.2025.177381_bib73","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10286020.2023.2270440","article-title":"Practical gram-scale synthesis of bicyclol metabolites M2 and M3","volume":"26","author":"Ma","year":"2024","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib74","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMc060733","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Madariaga","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2025.177381_bib76","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177381_bib77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7819-3-27","article-title":"Viral hepatitis and hepatocellular carcinoma","volume":"3","author":"Michielsen","year":"2005","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ejphar.2025.177381_bib78","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.12659\/MSM.904090","article-title":"A multicenter and randomized controlled trial of bicyclol in the treatment of statin-induced liver injury","volume":"23","author":"Naiqiong","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2025.177381_bib79","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1177050","article-title":"Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice","volume":"14","author":"Nisar","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib81","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib82","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1211\/jpp.59.12.0007","article-title":"Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice","volume":"59","author":"Pan","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib83","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Piche","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib84","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.177381_bib86","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3109\/03639045.2011.650643","article-title":"Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailability","volume":"38","author":"Ryu","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejphar.2025.177381_bib87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1515\/med-2017-0012","article-title":"Effect of bicyclol tablets on drug induced liver injuries after kidney transplantation","volume":"12","author":"Shang","year":"2017","journal-title":"Open Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib88","doi-asserted-by":"crossref","first-page":"10321","DOI":"10.1523\/JNEUROSCI.4014-05.2005","article-title":"A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo","volume":"25","author":"Shih","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177381_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.177381_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5935\/0101-2800.20170011","article-title":"Obesity and kidney disease","volume":"39","author":"Silva Junior","year":"2017","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.ejphar.2025.177381_bib91","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/HEP.0000000000000458","article-title":"Future directions in acute liver failure","volume":"78","author":"Stravitz","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.177381_bib92","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.canlet.2005.05.019","article-title":"Chemopreventive effect of bicyclol on malignant transformation of WB-F344 rat liver epithelial cells and its effect on related signal transduction in vitro","volume":"236","author":"Sun","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.177381_bib93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/10286020902942368","article-title":"Inhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanisms","volume":"11","author":"Sun","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584728","article-title":"A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model","volume":"2012","author":"Sun","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejphar.2025.177381_bib95","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2009.05.002","article-title":"Bicyclol attenuates oxidative stress and neuronal damage following transient forebrain ischemia in mouse cortex and hippocampus","volume":"459","author":"Sun","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177381_bib96","first-page":"97","article-title":"A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability","volume":"11","author":"Tan","year":"2008","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2025.177381_bib97","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1080\/00498250802460733","article-title":"Pharmacokinetics of bicyclol in rats with acute hepatic failure","volume":"38","author":"Tan","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2025.177381_bib98","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/liv.15290","article-title":"Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: a multicenter, randomized, phase II trial","volume":"42","author":"Tang","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2025.177381_bib99","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-2952(89)90208-6","article-title":"Tumor necrosis factor is a terminal mediator in galactosamine\/endotoxin-induced hepatitis in mice","volume":"38","author":"Tiegs","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib100","article-title":"Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database","volume":"49","author":"Wang","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib101","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12885-016-2767-2","article-title":"Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K\/AKT and Ras\/Raf\/MEK\/ERK pathways","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2025.177381_bib102","first-page":"2114s","article-title":"Aflatoxins as risk factors for hepatocellular carcinoma in humans","volume":"52","author":"Wogan","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib103","article-title":"Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis through modulating multiple pathways in mice","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib104","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.biopha.2017.05.041","article-title":"Bicyclol exerts an anti-tumor effect via ROS-mediated endoplasmic reticulum stress in human renal cell carcinoma cells","volume":"91","author":"Wu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177381_bib105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12072-011-9294-7","article-title":"A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol","volume":"6","author":"Xie","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejphar.2025.177381_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1037850","article-title":"Disease tolerance: a protective mechanism of lung infections","volume":"13","author":"Xu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177381_bib107","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1039\/C5TB00434A","article-title":"Biodegradable PLGA nanoparticles loaded with hydrophobic drugs: confocal Raman microspectroscopic characterization","volume":"3","author":"Yan","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejphar.2025.177381_bib108","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/00498254.2018.1524186","article-title":"Evaluation of pharmacokinetic interactions between bicyclol and co-administered drugs in rat and human liver microsomes in vitro and in rats in vivo","volume":"49","author":"Yang","year":"2019","journal-title":"Xenobiotica"},{"issue":"26","key":"10.1016\/j.ejphar.2025.177381_bib109","first-page":"421","article-title":"Efficacy and safety of bicyclol in treatment of 2 200 chronic viral hepatitis","volume":"24","author":"Yao","year":"2005","journal-title":"Chin. J. New Drugs Clin. Remedies"},{"key":"10.1016\/j.ejphar.2025.177381_bib110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1872-034X.2009.00504.x","article-title":"Protective effect of bicyclol on liver injury induced by hepatic warm ischemia\/reperfusion in rats","volume":"39","author":"Yao","year":"2009","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib111","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177381_bib113","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1742-7843.2008.00343.x","article-title":"Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice","volume":"104","author":"Yu","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2025.177381_bib114","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00204-008-0370-2","article-title":"Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice","volume":"83","author":"Yu","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2025.177381_bib115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2013.06.032","article-title":"Neuroprotective effect of bicyclol in rat ischemic stroke: down-regulates TLR4, TLR9, TRAF6, NF-\u03baB, MMP-9 and up-regulates claudin-5 expression","volume":"1528","author":"Zhang","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib116","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresbull.2013.11.001","article-title":"Bicyclol upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia","volume":"100","author":"Zhang","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2025.177381_bib117","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10557-023-07426-3","article-title":"Bicyclol alleviates streptozotocin-induced diabetic cardiomyopathy by inhibiting chronic inflammation and oxidative stress","volume":"38","author":"Zhang","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2025.177381_bib118","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.177381_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111609","article-title":"Bicyclol alleviates obesity-induced renal injury by inhibiting JNK and NF-\u03baB-mediated inflammation","volume":"129","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11655-018-2553-x","article-title":"Genotoxicity and embryotoxicity study of bicyclol methyl ether, main impurity in bicyclol","volume":"25","author":"Zhang","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.ejphar.2025.177381_bib121","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/br.2016.765","article-title":"Hepatitis B patients exhibiting mild alanine aminotransferase elevation: a comparative analysis of treatment with and without Bicyclol tablets","volume":"5","author":"Zhang","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.ejphar.2025.177381_bib122","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10286020.2015.1131678","article-title":"Bicyclol promotes toll-like 2 receptor recruiting inosine 5'-monophosphate dehydrogenase II to exert its anti-inflammatory effect","volume":"18","author":"Zhang","year":"2016","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2025.177381_bib123","first-page":"412","article-title":"[The protective effect of bicyclol on ischemia-reperfusion induced kidney injury in rats]","volume":"37","author":"Zhao","year":"2002","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2025.177381_bib124","article-title":"Bicyclol alleviates signs of BDL-induced cholestasis by regulating bile acids and autophagy-mediated HMGB1\/p62\/nrf2 pathway","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107308","article-title":"Therapeutic potential of bicyclol in liver diseases: lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine","volume":"91","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib126","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41420-022-01173-4","article-title":"Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice","volume":"8","author":"Zhao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177381_bib127","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2020.00463","article-title":"Bicyclol attenuates acute liver injury by activating autophagy, anti-oxidative and anti-inflammatory capabilities in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177381_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111874","article-title":"Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-\u03baB signaling pathways","volume":"141","author":"Zhao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177381_bib129","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.3748\/wjg.v21.i23.7155","article-title":"Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats","volume":"21","author":"Zhen","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177381_bib130","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.177381_bib131","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jcb.29310","article-title":"Protective effect of bicyclol against pulmonary fibrosis via regulation of microRNA-455-3p in rats","volume":"121","author":"Zhou","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2025.177381_bib132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4161\/cbt.5.5.2655","article-title":"Chemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated p-glycoprotein, GST-P and Bcl-2","volume":"5","author":"Zhu","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2025.177381_bib133","first-page":"923","article-title":"Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice","volume":"9","author":"Zhu","year":"2015","journal-title":"Drug Des. Dev. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:17:23Z","timestamp":1741349843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":133,"alternative-id":["S0014299925001347"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177381","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the horizons of bicyclol in multiple diseases: Mechanisms, therapeutic implications and challenges","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177381"}}